aetiopathological and clinical study of Madhumeha with special reference to Type 2 Diabetes Mellitus

Nidanatmak(aetiopathological) and upashayatmak(clinical )study of Madhumeha with special reference to Type 2 Diabetes Mellitus

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045137

Enrollment

100

Registered

2022-09-01

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Inclusion Criteria Ã¢â?¬â?? Patients between age group 30 to 60 years. Newly Diagnosed cases of Diabetes mellitus less than 6months FBS- 130-160 mg/dl and PP- 150- 220mg/dl HbA1c

Exclusion criteria

Exclusion criteria: 1. Patients of age less than 20 years and above 60 years. 2. Pregnant woman 3. Patients with serious disorders like MI, CHF, cirrhosis of liver, severe complicated DM. 4. Patients taking drugs like corticosteroids, antidepressant

Design outcomes

Primary

Measure	Time frame
Sample Size-100 patients Group-2 Group A -50 patients and GroupB-50 patients Test- Paired T Test Wilcoxon matched pairs Signed rank test Timepoint: Time Points Completion of trail- 2 Years Duration of trail-90 days Follow up-15 days 30 days 45 days 60 days 75 days 90 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Rekha

Dypatil University School of Ayurveda

Santosh.chavhan@gmail.com9167778502

Outcome results